*1.Please select which Conference presentation you are rating. You can only rate one presentation at the time.(Required.)

Role of CFTR Arginine-933 in FDA-Approved Drug Potentiation - Stephen Aller, PhDNanotechnology Toolkits for Cystic Fibrosis Gene Therapies – Steven Jonas, MD, PhDDevelopment of Bacteriophage Therapy for Antimicrobial-Resistant Infections in CF – Paul Bollyky, MD, PhDAirway Stem Cell Transplantation into the Sinuses Using Fibrinogen Scaffold – Sriram Vaidyanathan, PhDTolerance to Cell Permeable Antibiotics: Intracellular Adaptations of Pseudomonas aeruginosa - Naren Kumar, PhDTargeting IRBIT to Correct Bicarbonate Secretory Defects in Cystic Fibrosis – Zachary Sellers, MD, PhDImproving CF Airway Mucociliary Clearance: Toward Transition from Animals to Humans - Carlos Milla, MD; Nam Soo Joo, PhDPathways Balancing Basal Mucin and CFTR-Mediated Fluid Secretion in the Human Distal Airway - Kenichi Okuda, MD, PhDA Journey Through Rare: Because EVERYONE Deserves More Tomorrows - Rachel AlderPhage Therapy - Saima Aslam, MD, MSAll Hands on Deck to Cure Cystic Fibrosis - Matthew Porteus, MD, PhDUnderstanding and Managing Pain in CF: A Biopsychosocial Approach - Deborah Friedman, PhD; Amanda Bruce, PhDFrom Defining Health Disparities to Improving Health Equity in Cystic Fibrosis - Susanna A. McColley, MD, FAAP, ATSFPanel: Paths to Parenthood – Lucy Barnes, Matthew DeFina, Carl Robinson; moderated by Mary Helmers, RNAdvances in mRNA Therapy: New Applications for Cystic Fibrosis – Deepika Polineni, MD, MPHEmbracing the Future: Aging with CF - Ahmet Uluer, DO, MPHColon Cancer and Cystic Fibrosis: My Lived Experience – Anna PayneAdvances in Stem Cell Research for the Treatment of CF – Brigitte Gomperts, MDTurning Struggles Into Strengths – Alanah Rosenbloom, MSW

*2.How effective was the presenter in conveying the content clearly?(Required.)

Extremely effective

Very effective

Somewhat effective

Not effective

*3.How would you rate this presentation as a whole?(Required.)

Excellent

Very good

Good

Poor

4.Additional comments?